Deadly painkiller!
Some leading drug companies are producing and marketing a painkiller having deadly effect on human body as what they said the local drug administration did not impose any restriction on it.
bdnews24.com News Service
bdnews24.com
Published :
22 Jul 2005, 06:00 PM
Updated :
18 Aug 2022, 11:45 AM
Dhaka July 23 (BDNEWS) - Some leading drug companies are producing and marketing a painkiller having deadly effect on human body as what they said the local drug administration did not impose any restriction on it.
The main manufacturer of the drug, Pfizer Inc, already stopped marketing of the drug in the USA in April.
Pfizer withdrew its research product "Bextra", generic name of which is "valdecoxib", following reports of adverse effect of the drug from the FDA (Food and Drug Administration), the US drug regulatory body.
Only Novartis, a Swiss-based multinational, abandoned production of the drug and withdrew it from the local market.
Others said the painkiller increases the risk of heart attack of arthritis patients, but the local Directorate of Drug Administration (DDA) has not imposed any restriction. Also the medicine has no alternative right at this moment, they said.
This painkiller is commonly used for pain related to arthritis and primary dysmenorrhoea.
Officials at the DDA said they know the side effect of the medicine but did not put the restriction as Bangladesh does not follow the recommendations of the FDA of the USA; it follows the WHO (World Health Organisation) guidelines.
"If the WHO recommends us to withdraw this product, we will do it," said Habibur Rahman, director of the DDA.
Dismissing the FDA's concern, he said: Had the drug been so harmful, the WHO would have banned it."
He said the drug is still being marketed in other countries.
Nazmul Hassan, secretary general of the Bangladesh Association of Pharmaceutical Industries (BAPI), said: We did not know that Pfizer stopped marketing of the product -- we only knew that Pfizer has warned about some serious side effects of the medicine.
"We will check that out and take necessary steps," he told BDNEWS.
BDNEWS/1701 hrs